Graves眼病-话题@MedSci

#Graves眼病#

12篇内容 | 828人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2144027, encodeId=543d214402e43, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>学习受益, objectTitle=Graves眼病, objectType=topic, longId=8249, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=19, createdTime=2023-06-21, rootId=0, userName=ms2000000147841561, userId=5bf26472850, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515321, encodeId=3cc61515321e0, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, objectType=article, longId=735191, objectId=e73fe3519133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73fe3519133, replyNumber=0, likeNumber=31, createdTime=2022-08-09, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73fe3519133, moduleTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e73fe3519133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515320, encodeId=cbee151532070, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）, objectType=article, longId=217495, objectId=8b2921e49547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b2921e49547, replyNumber=0, likeNumber=30, createdTime=2021-09-24, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b2921e49547, moduleTitle=Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b2921e49547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515319, encodeId=a3291515319b8, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？, objectType=article, longId=216732, objectId=b3fe216e3245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3fe216e3245, replyNumber=0, likeNumber=38, createdTime=2021-09-07, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3fe216e3245, moduleTitle=JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3fe216e3245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515318, encodeId=c79e15153181f, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效, objectType=article, longId=216674, objectId=c00c2166e4fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c00c2166e4fb, replyNumber=0, likeNumber=40, createdTime=2021-09-05, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c00c2166e4fb, moduleTitle=JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c00c2166e4fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515317, encodeId=6563151531e41, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=HBM9161针对Graves眼病的临床试验获NMPA批件, objectType=article, longId=195214, objectId=8696195214be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8696195214be, replyNumber=0, likeNumber=37, createdTime=2020-06-04, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8696195214be, moduleTitle=HBM9161针对Graves眼病的临床试验获NMPA批件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8696195214be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515316, encodeId=2cf7151531636, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=“Graves眼病” 越治越重！主治医生该何去何从？, objectType=article, longId=180825, objectId=b4901808257f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4901808257f, replyNumber=0, likeNumber=43, createdTime=2019-10-11, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4901808257f, moduleTitle=“Graves眼病” 越治越重！主治医生该何去何从？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4901808257f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515315, encodeId=c79c151531554, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=Graves眼病4种治疗方案汇总，快收藏！, objectType=article, longId=158488, objectId=7fdf1584880e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fdf1584880e, replyNumber=0, likeNumber=33, createdTime=2019-01-22, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fdf1584880e, moduleTitle=Graves眼病4种治疗方案汇总，快收藏！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fdf1584880e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515314, encodeId=5c751515314f5, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=Invest Ophthalmol Vis Sci：磷脂酰肌醇3-激酶特异性抑制剂Idelalisib对Graves眼病的脂肪生成具有抑制作用, objectType=article, longId=148600, objectId=044214860080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044214860080, replyNumber=0, likeNumber=39, createdTime=2018-09-12, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044214860080, moduleTitle=Invest Ophthalmol Vis Sci：磷脂酰肌醇3-激酶特异性抑制剂Idelalisib对Graves眼病的脂肪生成具有抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044214860080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515313, encodeId=e3881515313da, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=Endocrine：活跃的Graves眼病患者的泪液中细胞因子图谱！, objectType=article, longId=124890, objectId=4883124890b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4883124890b5, replyNumber=0, likeNumber=30, createdTime=2017-12-29, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4883124890b5, moduleTitle=Endocrine：活跃的Graves眼病患者的泪液中细胞因子图谱！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4883124890b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515312, encodeId=02ca1515312fa, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=Thyroid：自噬与Graves眼病的发生发展相关, objectType=article, longId=49859, objectId=86fd49859e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86fd49859e8, replyNumber=0, likeNumber=38, createdTime=2015-04-26, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86fd49859e8, moduleTitle=Thyroid：自噬与Graves眼病的发生发展相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86fd49859e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515311, encodeId=541c15153118f, content=<a href='/topic/show?id=b3e18249d3' target=_blank style='color:#2F92EE;'>#Graves眼病#</a>, objectTitle=Eye：眼部手术对Graves眼病患者血-房水屏障完整性的影响, objectType=article, longId=47325, objectId=b7294e325b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7294e325b7, replyNumber=0, likeNumber=34, createdTime=2015-02-22, rootId=0, userName=若水126, userId=3e2210763438, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7294e325b7, moduleTitle=Eye：眼部手术对Graves眼病患者血-房水屏障完整性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7294e325b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

ms2000000147841561 (审核中...)

前往app查看评论内容

#Graves眼病#学习受益

2023-06-21

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读

2022-08-09

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）

2021-09-24

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？

2021-09-07

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效

2021-09-05

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

HBM9161针对Graves眼病的临床试验获NMPA批件

2020-06-04

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

“Graves眼病” 越治越重！主治医生该何去何从？

2019-10-11

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

Graves眼病4种治疗方案汇总，快收藏！

2019-01-22

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

Invest Ophthalmol Vis Sci：磷脂酰肌醇3-激酶特异性抑制剂Idelalisib对Graves眼病的脂肪生成具有抑制作用

2018-09-12

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

Endocrine：活跃的Graves眼病患者的泪液中细胞因子图谱！

2017-12-29

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

Thyroid：自噬与Graves眼病的发生发展相关

2015-04-26

若水126 (审核中...)

前往app查看评论内容

#Graves眼病#

Eye：眼部手术对Graves眼病患者血-房水屏障完整性的影响

2015-02-22

科室
- - 订阅+
  - 更多科室
工具
服务